Charles river joins elly's team to drive rare disease gene therapy development

Wilmington, mass.--(business wire)---- $crl #lifeatcrl--as part of charles river's cell & gene therapy accelerator program, elly's team manufactured critical starting materials for a phase i clinical trial.

CRL Ratings Summary

CRL Quant Ranking